Insider
AbbVie Inc.ABBV

AbbVie executives conducted stock transactions in mid-November

AbbVie Inc. executives Jeffrey R. Stewart and Azita Saleki-Gerhardt conducted a series of company stock transactions between November 9 and November 16, 2026. The executives exercised stock options and filed notices of proposed sales as part of managing their personal equity holdings.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
room with glass divider and white curtain
Photo by Nastuh Abootalebi on Unsplash
40,619
Shares sold
13,481
Proposed sale
3,450
Shares gifted

Key points

  • Jeffrey R. Stewart, executive vice president and chief commercial officer, exercised options to acquire 40,619 shares on November 9, 2026.
  • Aside from option transactions, Jeffrey R. Stewart gifted 3,450 company shares on November 12, 2026.
  • External observers may view insider stock sales, even those linked to option exercises, as a signal of reduced confidence in the company’s value.

Executive stock transactions

Jeffrey R. Stewart, executive vice president and chief commercial officer, exercised options to acquire 40,619 shares on November 9, 2026. He sold the same number of shares on the open market that day. Following these transactions, he holds 83,171 AbbVie shares.

On November 16, 2026, Azita Saleki-Gerhardt filed a notice of a proposed sale for 13,481 shares acquired through option exercises. It is important to note that such a notice does not mean the sale has already occurred.

Proposed sales (Form 144), by insider

AZITA SALEKI-GERHARDT$4,024,850.96JEFFREY R STEWART$11,925,848.07
Data from the original sources listed alongside.

Other ownership changes

Aside from option transactions, Jeffrey R. Stewart gifted 3,450 company shares on November 12, 2026. His AbbVie stake decreased to 79,721 shares after this transaction.

Risks for shareholders

External observers may view insider stock sales, even those linked to option exercises, as a signal of reduced confidence in the company’s value. Executive trades are personal financial decisions and do not indicate changes to AbbVie’s outlook or financial policy.

What to watch

Shareholders should monitor future insider transaction reports in the SEC EDGAR database. These filings will indicate whether executives continue to divest shares or if they initiate new transactions to maintain holdings.

Original sources

  1. 144 filing, November 9, 2026November 9, 2026SHA-256 of our archived copy de287da51bad…
  2. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy c6141e0263ab…
  3. 144 filing, November 16, 2026November 16, 2026SHA-256 of our archived copy bb6a505c82af…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards